Profile of tivozanib and its potential for the treatment of advanced renal cell carcinoma.

Drug Des Devel Ther · 2013 · PMC3693745 · PMID 23818763

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Additionally, dynamic contrast enhanced magnetic resonance imaging was performed in eight patients and showed a trend towards decreased intratumoral vascularity.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.